prostate cancer

Educational Objectives In this activity, experts in prostate cancer discuss cardiovascular risk in patients receiving androgen-deprivation therapy (ADT). Upon completion of this activity, participants should be better able to: Evaluate the impacts of prostate cancer and ADT on...

Dr. Samantha Strumeier * There's absolutely no evidence that testosterone replacement therapy causes prostate cancer, there's a lack of long-term data but I think you know we have a lot more data keeps coming out over the years and we should really hone in on that...

Dr. Strumeier spent most of her career at MSK under the legendary Dr. Mulhall! https://simplyoncology.buzzsprout.com/2342317/episodes/19577727-episode-113-in-the-clinic-managing-low-testosterone-in-cancer-with-dr-samantha-strumeier Join us as we cover the effect of cancer and its treatment...

Eye opener! Must listen for any man struggling with sides on standard LHRH-based ADT. * He is a PhD evolutionary biologist, former professor of anatomy and neurobiology, prostate cancer quality-of-life researcher, co-developer of an androgen deprivation education program, and a patient who has...

Dr. Tarik Benidir and Dr. Ruchika Talwar discuss smarter use of repeat testing, patient education, and why age and prostate size are key context clues.

Most men who undergo a prostate biopsy may not have cancer found at all—and the bigger mistake may be rushing from a single elevated PSA straight to the needle. Dr. James Wysock, an NYU urologist with deep expertise in prostate cancer diagnostics and image-guided biopsy, explains why the modern...

Two heavy weights in the field drop a big one! * Sixty-five years after the landmark publication by Huggins and Hodges, it was discovered that their principal conclusion that T injections “activated” PCa even in hormonally intact men was based on erratic acid phosphatase results in a single...

In this episode, Dr. Brandon & Dr. Morgentaler talk about what high PSA levels really mean, their relationship to prostate cancer, and why an elevated PSA doesn’t necessarily rule out testosterone therapy after proper evaluation. Timestamps 00:00 PSA Basics Explained — PSA is a normal...

* “Active surveillance is about safely managing low-risk prostate cancer while preserving quality of life,” said Sanoj Punnen, M.D., professor of urologic oncology at the Miller School and DSUI vice chair of research. “For some men, maintaining quality of life may include testosterone...

* PSA is biologically useful but clinically imprecise, often leading to false positives, unnecessary biopsies, and detection of indolent disease. 04:03 - Why PSA Can Be Misleading 06:43 - Approach to Elevated PSA and Initial Workup Is an elevated prostate-specific antigen (PSA) the...

If you've been told you need a prostate biopsy, you may be wondering whether a transrectal biopsy or a transperineal biopsy is the better option. In this episode of UroPatient, Vic Senese, RN, BSN, FAUNA, explains the key differences between these two prostate biopsy techniques and what current...

Learning Objectives Take Home Points

Abraham Morgentaler, MD, joins Neil Baum, MD, to discuss the historical origins of the belief that testosterone drives prostate cancer and the new framework presented in his recent Journal of Urology publication.

https://www.urotoday.com/conference-highlights/apccc-2026/168579-apccc-2026-the-importance-of-baseline-testosterone-and-testosterone-recovery-in-high-risk-and-locally-advanced-prostate-cancer.html Taken together, the absence of testosterone recovery seems to be associated with worse overall...

Daniel A. Hamstra, MD, PhD, FASTRO, FASCO, Chief of Radiation Oncology, Baylor College of Medicine, Houston, Texas, presents an in-depth review of rectal spacing devices in modern prostate radiation therapy. He explains how dose-volume relationships drive rectal toxicity and how rectal spacers...

* To date there's only been one randomized study testing BAT 14:05 Stop & Watch: The TRANSFORMER trial—did BAT actually work? For decades, men with prostate cancer have been told that testosterone is like gasoline on a fire. But what if, under the right conditions, testosterone could...

In this episode, Dr. Brandon and Dr. Morgentaler talk about the FDA's groundbreaking testosterone label changes, the evolving evidence on testosterone therapy and prostate cancer, and how quality of life should factor into treatment decisions for men with advanced disease. Time stamps...

The FDA's proposed narrowing of the testosterone therapy prostate cancer contraindication to metastatic disease only reflects current clinical evidence, opening the door to testosterone therapy in appropriately selected men with treated localized prostate cancer or on active surveillance, with...

AUA Guidelines: Advanced Prostate Cancer Host: Mark L. Gonzalgo, MD, PhD, MBA Guest: Kristen R. Scarpato, MD, MPH https://www.auanet.org/guidelines-and-quality/guidelines/advanced-prostate-cancer

Chapters 00:00 Introduction 00:23 Hormone Therapy and Sexual Function 04:06 Penile Shrinkage During Hormone Therapy 05:12 Cialis and Viagra During ADT 05:31 When to Start Cialis or Viagra 05:51 Is It Too Late to Restore Erectile Function? 06:34 When Cialis or Viagra Aren't Enough 07:25 What If...

In this eye-opening episode of the Dr. Geo Prostate Podcast, Dr. Geo sits down with world-renowned exercise oncology researcher Professor Robert Newton, founder of the Exercise Medicine Research Institute and one of the leading voices in cancer exercise science. Discover why exercise is now...

* 08:22 Testosterone Recovery and Restoring Libido Timelines 00:00 Sexual Function After Radiation: What to Expect 00:52 Radiation vs. Surgery: Key Differences in Recovery 01:50 Hormone Therapy and Erectile Dysfunction Risks 02:32 Maintaining Sexual Function During Treatment 02:53 PCRI...

What if the persistent pelvic pain, the performance issues in the bedroom, or that nagging brain fog isn't just a physical "glitch," but a physical manifestation of an underlying mental struggle? Most men are trained to wear a mask in the clinic, but the body always keeps the score. When a man...

Radiation therapy is a highly effective treatment for prostate cancer. Navigating potential side effects, particularly radiation effects on the rectum, is a key challenge when making a decision. Fortunately, a new technology helps reduce the short- and long-term risks associated with treatment...

https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2848537#google_vignette

What if your prostate biopsy is missing the most important detail? In this powerful episode, Dr. Geo sits down with Dr. Jonathan Epstein, one of the most influential urologic pathologists in the world, to break down what’s really happening behind your diagnosis. From Gleason scores to hidden...

* Dr. Tombal recommends relugolix, an oral GnRH antagonist that restores normal testosterone within 90 to 120 days, when ADT is required, and notes that patients who fail to recover normal testosterone have worse prognosis. * He also supports testosterone supplementation in symptomatic...

Explore the definitive findings of the "European Study of Prostate Cancer Screening — 23-Year Follow-up" to understand how long-term prostate cancer screening significantly impacts patient survival. Maurie Markman, MD, provides a detailed analysis of this landmark study, highlighting a 13%...

This expert panel discussion at the Southwest Prostate Cancer Symposium explores how prostate cancer screening and diagnostic decisions are made in real clinical practice. The conversation begins by discussing historical prostate-specific antigen (PSA) thresholds and why PSA alone is...